Skip to main content

Table 1 Summary of plasma metabolite specimens and measurements

From: Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes

Measurement

Vendor

Source Clinical Sites

No. Participants (per protocol)

No. Plasma Specimens

No. times thawed prior to measurement

Targeted SCFA

Metabolon

Sites 1–5

51

104

1

Untargeted

Metabolon

Sites 1–5

51

104

1

Targeted Bile Acids

MS-Omics

Sites 1–5

51

104

2

Untargeted

MS-Omics

Site 6

10 (4)

20

1